Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

We tend to see weight loss as aspirational, but having a bit of extra fat isn’t always bad for us – and weight loss isn’t ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Eating carefully and exercising regularly, yet the scale refuses to move? Thyroid health could be the missing link. As ...